🔎 Trials Near Me

Beranda › Kanker Payudara › Connecticut › Hartford

Uji klinis Kanker Payudara di Hartford, CT

9 studi untuk Kanker Payudara mencari peserta di lokasi sekitar Hartford (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study

Menerima pesertaFase 3
  • Smilow Cancer Hospital at Saint Francis, Hartford
  • Smilow Cancer Hospital at Glastonbury, Glastonbury · 5 mi jauhnya
Usia 60 ke atas · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06377852

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

Menerima peserta
  • Hartford Healthcare Institute, Hartford
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07214532

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Menerima pesertaFase 3
  • Hartford Hospital, Hartford
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi jauhnya
  • dan 3 lainnya
Usia 18 hingga 60 · Wanita · Diperbarui 2 Sep 2026 · NCT05879926

ATEMPT 2.0: Adjuvant T-DM1 vs TH

Menerima pesertaFase 2
  • Smilow Cancer Hospital Care center at St. Francis, Hartford
  • Smilow Cancer Hospital Care center at Glastonbury, Glastonbury · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 19 Agu 2026 · NCT04893109

Integrated Cancer Repository for Cancer Research

Menerima pesertaStudi observasionalSukarelawan sehat diterima
  • Hartford HealthCare Cancer Institute at Manchester Medical Hospital, Manchester · 8 mi jauhnya
Usia 19 hingga 110 · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT02012699

A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.

Menerima pesertaFase 3
  • Smilow Cancer Hospital at Saint Francis, Hartford
  • Smilow Cancer Hospital - Glastonbury, Glastonbury · 5 mi jauhnya
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 6 Mei 2026 · NCT07062965

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

Menerima pesertaFase 3
  • Smilow Cancer Hospital Care Center at Saint Francis, Hartford
  • Smilow Cancer Hospital Care Center at Glastonbury, Glastonbury · 5 mi jauhnya
Usia 50 hingga 70 · Semua jenis kelamin · Diperbarui 23 Apr 2026 · NCT04852887

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

Menerima pesertaFase 2
  • Hartford Healthcare, Hartford
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Feb 2026 · NCT03808337

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Hartford
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Kanker Payudara di kota lain

Studi lain di Hartford

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.